Skip to main content
Valiant Laboratories Limited logo

Valiant Laboratories Limited — Investor Relations & Filings

Ticker · VALIANTLAB ISIN · INE0JWS01017 LEI · 335800VKNJKWJ4LD6855 BSE.NS Manufacturing
Open in API
Filings indexed 173 across all filing types
Latest filing 2024-08-15 Regulatory Filings
Country IN India
Listing BSE.NS VALIANTLAB

About Valiant Laboratories Limited

https://www.valiantlabs.in/

Valiant Laboratories Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs, with a primary focus on the production of Paracetamol. The company operates dedicated manufacturing facilities designed for the large-scale synthesis of analgesic and antipyretic compounds. By maintaining rigorous quality control standards and process efficiencies, it serves as a key supplier for formulations across various therapeutic segments. Its core business activities encompass the chemical processing and distribution of high-grade medicinal ingredients, catering to a diverse range of healthcare manufacturers. The organization prioritizes technical excellence in API synthesis and the optimization of production workflows to ensure a consistent supply of essential pharmaceutical components.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a corrigendum to a newspaper publication of financial results for the quarter ended June 30, 2024. It references compliance with SEBI (LODR) Regulations, 2015, and mentions a previous letter dated August 14, 2024. The document does not contain actual financial data or detailed financial statements but rather is an announcement related to the publication of financial results. The document length is short (1809 characters), and it primarily serves as a notification or correction to a previously published financial result announcement. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER).
2024-08-15 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a Statement of Deviation or Variation of Funds under Regulation 32 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It specifically states that there is no deviation or variation in the utilization of IPO proceeds for the quarter ended June 30, 2024. The content is a compliance disclosure about fund utilization and deviations, which is a regulatory filing requirement under SEBI regulations. The document is relatively short (4027 characters) and is an official statement rather than a full financial report or audit. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-14 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report' and is issued pursuant to Regulation 32 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It specifically relates to the utilization of proceeds from the company's Initial Public Offer (IPO) for the quarter ended June 30, 2024. The report is prepared by CARE Ratings Limited, the Monitoring Agency, and includes detailed tables on the use of IPO proceeds, deviations, and certifications by a Chartered Accountant. The document is about monitoring the use of IPO funds and is a regulatory compliance report rather than a full annual or quarterly financial report. It is not an announcement of a report but the report itself, containing substantive financial and compliance data related to IPO proceeds utilization. This fits the category of a specialized regulatory compliance report related to capital raising and monitoring, which aligns best with the 'Capital/Financing Update' category (CAP).
2024-08-14 English
Copy of Newspaper Publication
Regulatory Filings
2024-08-14 English
Financial Result Updates
Regulatory Filings
2024-08-12 English
Outcome of Board Meeting
Regulatory Filings
2024-08-12 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.